Financial News Discussion of BMY - Bristol-Myers Squibb Company on Mad Money

Financial News for Bristol-Myers Squibb Company (BMY)

BMY	3/16/2010 4:00PM	52 Week Price Range	Market Capitalization	Dividend Yield	Recent Dividend
BMY	$25.99	$18.83 — $26.62	$44.5 Billion	4.90%	$1.25

Want to Sharpen Your Investing?

Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.

Explore Why Ockham?

Quality Analysis

Ockham has fundamental valuations on over 5000 companies which we distribute, to our clients via highly-focused equity reports, weekly newsletters, and analysts' daily market commentary blogs. (Learn More)

Crowd Sentiment

Through our partnership with The Motley Fool, Ockham provides the most robust data on investors' sentiment of individual stocks. This indicator, along with our valuations and our news tracking, helps our clients make informed investment decisions. (Learn More)

Financial News Slicing

With the influx of noise in our lives, it can be exceedingly difficult to separate the essential news from everything else. Ockham's RazorWire tool "slices" through business television and impactful blogs to provide you with the clearest information possible. (Learn More)

Bristol-Myers Squibb Company was discussed on Mad Money which was originally produced by CNBC on 1/22/2010

Mad Money discussed Bristol-Myers Squibb Company on 1/22/10. Jim Cramer, who highlights news and stocks each day at 6:00 PM, mentioned Bristol-Myers Squibb Company on the program. The mention with surrounding context is displayed below.

If BMY's dividends are important to you, take a look at the news as they were the topic of conversation on Mad Money.

As we analyze the results from RazorWire, one thing we do is rank each stock in terms of amount of news coverage. Recently, BMY has been less covered in the news compared to the rest of our universe of stocks. We consider BMY as Undervalued at the current price of $24.65. According to our methodology, this stock has appreciation potential based on current fundamentals which only improves if earnings or revenue surprise. The Motley Fool CAPS data suggests that investors believe Bristol-Myers Squibb Company will beat the market in the foreseeable future.

“That's like BRISTOL MYERS, 5% yield, which my charitable trust owns. We like wellpoint, the least affected by washington.” Mad Money Jan 22, 2010 6:29 PM

Some important items we've observed:

Bristol-Myers Squibb Company BMY has increased in price by 5.11% since it was mentioned on Mad Money.
Jim Cramer mentioned quite a few stocks, 29 individual companies to be exact. You can see the all company slices for Mad Money on the recap page.
As far as Mad Money on Friday, January 22, 2010, this is the only mention for Bristol-Myers Squibb Company.
There have been 2 mentions of Bristol-Myers Squibb Company BMY since being mentioned on Mad Money on Friday, January 22, 2010. Ockham details all of the news on Bristol-Myers Squibb Company on our BMY Financial News page.
The most active stock on Mad Money over the last 2 weeks has been Apple, Incorporated.